Kei Moriya

Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake

Kosuke Kaji, Norihisa Nishimura, Kenichiro Seki et al. · International Journal of Cancer · 2017 · 242 citations

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

Kosuke Kaji, Hiroaki Takaya, Soichiro Saikawa et al. · World Journal of Gastroenterology · 2017 · 99 citations · Full text

Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway

Koji Ishida, Kosuke Kaji, Shinya Sato et al. · The Journal of Nutritional Biochemistry · 2020 · 84 citations

Inflammation, Acetaldehyde Metabolization, Hepatology +14

Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis

Masanori Furukawa, Kei Moriya, Jiro Nakayama et al. · Hepatology Research · 2020 · 76 citations

von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C

Hiroaki Takaya, Hideto Kawaratani, Yuki Tsuji et al. · United European Gastroenterology Journal · 2018 · 48 citations · Full text